(Q34437998)

2 August 2017

1 reference

MDMA

0 references

title

3,4-methylenedioxymethamphetamine (MDMA): a review (English)

1 reference

2 August 2017

O'Leary G

1

1 reference

2 August 2017

Nargiso J

series ordinal

2

1 reference

2 August 2017

Weiss RD

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Current Psychiatry Reports

2 August 2017

1 reference

2 August 2017

3

1 reference

2 August 2017

6

1 reference

2 August 2017

477-483

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-001-0041-y

2 August 2017

0 references

cites work

The background and chemistry of MDMA.

1 reference

https://api.crossref.org/works/10.1007%2FS11920-001-0041-Y

Subjective reports of the effects of MDMA in a clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-001-0041-Y

Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-001-0041-Y

Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-001-0041-Y

Sweat testing of MDMA with the Drugwipe analytical device: a controlled study with two volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-001-0041-Y

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-001-0041-Y

MDMA. Nonmedical use and intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-001-0041-Y

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-001-0041-Y

An "accidental" acute psychosis with ecstasy use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-001-0041-Y

Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-001-0041-Y

Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-001-0041-Y

Psychiatric sequelae of MDMA (ecstasy) and related drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-001-0041-Y

Ecstasy induced hepatitis mimicking viral hepatitis

21 January 2018

1 reference

12 December 2020

Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain

1 reference

12 December 2020

Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain

1 reference

12 December 2020

Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.

1 reference

12 December 2020

3,4-Methylenedioxyamphetamine Overdose

1 reference

12 December 2020

MDMA (Ecstasy) precipitation of panic disorder

1 reference

12 December 2020

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

1 reference

12 December 2020

"Ecstasy" and sudden cardiac death

1 reference

12 December 2020

Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage

1 reference

12 December 2020

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

1 reference

12 December 2020

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.

1 reference

12 December 2020

Cognitive performance and serotonergic function in users of ecstasy.

1 reference

12 December 2020

'Rave' scene, ecstasy use, leap atlantic

1 reference

12 December 2020

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

1 reference

12 December 2020

Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).

1 reference

12 December 2020

Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?

1 reference

12 December 2020

Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')

1 reference

12 December 2020

Fatal intoxication from 3,4-methylenedioxyamphetamine

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys

1 reference

12 December 2020

Information on "Ecstasy"

1 reference

12 December 2020

Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations

1 reference

12 December 2020

Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low.

1 reference

12 December 2020

"Ecstasy" (MDMA)-induced panic.

1 reference

12 December 2020

'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA

1 reference

12 December 2020

Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations

1 reference

12 December 2020

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users

1 reference

12 December 2020

Chemical analysis of ecstasy pills

1 reference

12 December 2020

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.

1 reference

12 December 2020

Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.

1 reference

12 December 2020

Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

1 reference

12 December 2020

Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS

1 reference

12 December 2020

Aortic dissection after ingestion of "ecstasy" (MDMA)

1 reference

12 December 2020

‘Ecstasy’ Psychosis and Flashbacks

1 reference

12 December 2020

Ecstasy (MDMA): a review of its possible persistent psychological effects

1 reference

12 December 2020

Chronic ecstasy (3,4-methylenedioxymetamphetamine) abuse: a recurrent and unpredictable cause of severe acute hepatitis

1 reference

12 December 2020

Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors

1 reference

12 December 2020

Ecstasy returns to Schedule I

1 reference

12 December 2020

Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.

1 reference

12 December 2020

Chronic atypical psychosis associated with MDMA ("ecstasy") abuse

1 reference

12 December 2020

A fatal case involving methylenedioxyamphetamine.

1 reference

12 December 2020

Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use

1 reference

12 December 2020

Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat.

1 reference

12 December 2020

Ecstasy, 3–4 Methylenedioxymethamphetamine (MDMA), a Fatality Associated with Coagulopathy and Hyperthermia

1 reference

12 December 2020

Another death from Ecstacy

1 reference

12 December 2020

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.

1 reference

12 December 2020

Raves: a review of the culture, the drugs and the prevention of harm.

1 reference

12 December 2020

Ecstasy--long-term effects on the human central nervous system revealed by positron emission tomography

1 reference

12 December 2020

Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users

1 reference

12 December 2020

Hyponatraemia and catatonic stupor after taking "ecstasy".

1 reference

12 December 2020

Chronic paranoid psychosis after misuse of MDMA ("ecstasy")

1 reference

12 December 2020

Ecstasy-fueled 'rave' parties become dances of death for English youths.

1 reference

12 December 2020

Psychiatric illness associated with "ecstasy".

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.

1 reference

12 December 2020

Cerebral infarction associated with 3,4-methylenedioxymethamphetamine ('Ecstasy') abuse

1 reference

12 December 2020

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

1 reference

12 December 2020

Subarachnoid haemorrhage associated with MDMA abuse

1 reference

12 December 2020

A fatal trip with ecstasy: a case of 3,4-methylenedioxymethamphetamine/3,4- methylenedioxyamphetamine toxicity

1 reference

12 December 2020

Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine.

1 reference

12 December 2020

Patterns of recreational drug use at dance events in Edinburgh, Scotland

1 reference

12 December 2020

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

1 reference

12 December 2020

(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates

1 reference

12 December 2020

10.1007/S11920-001-0041-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference